Key result
Rhein plus honokiol reduces pancreatic injury, inflammation, and necrosis in acute pancreatitis.
Why the study?
Acute pancreatitis is a self-limiting inflammatory disease with high mortality when severe, and the effects of rhein and honokiol on AP are not well understood.
Does the combination of rhein and honokiol improve pathological changes and metabolic profiles in a mouse model of acute pancreatitis?
RCT (n=30)
randomly divided
Does the combination of rhein and honokiol improve pathological changes and metabolic profiles in a mouse model of acute pancreatitis?
The combination of rhein and honokiol ameliorates pathological changes and alters metabolic profiles in a mouse model of acute pancreatitis.
Provides preclinical support for rhein-honokiol in acute pancreatitis; leaves open translation to human therapy.
BACKGROUND Acute pancreatitis (AP) is generally a self-limiting inflammatory disease, but is associated with a high mortality rate when severe. The present study aimed to investigate the effects of rhein and honokiol on AP. MATERIAL AND METHODS Thirty mice were randomly divided into 5 groups (n=6 per group): blank control, AP model, AP+rhein, AP+honokiol, and AP+rhein+honokiol. The AP model was prepared by intraperitoneal injection of cerulein and lipopolysaccharide (LPS). We observed the pathological changes of the pancreas by hematoxylin and eosin (H&E) staining. A mouse amylase kit was utilized to detect the level of amylase content in serum. Gas chromatography mass spectrometer analysis was performed to detect the differences in metabolites among the blank control, AP model, and AP+rhein+honokiol groups. RESULTS The serum amylase level was significantly higher in the AP model, which suggested that the AP model was constructed successfully. The AP+rhein+honokiol group had significantly reduced interstitial edema, inflammatory cell infiltration, hemorrhage, and necrosis. In addition, the rhein and honokiol treatment influenced some of the metabolic pathways in AP, including riboflavin metabolism, glycerophospholipid metabolism, linoleic acid metabolism, and the pentose and glucuronate interconversions pathway. CONCLUSIONS This study showed that the combination of rhein and honokiol ameliorated pathological changes in the pancreas of mice with AP.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2020) conducted an RCT in Acute pancreatitis (n=30). Rhein and honokiol vs. Blank control, AP model, AP+rhein, AP+honokiol was evaluated on Pathological changes of the pancreas and metabolic profiles. The combination of rhein and honokiol significantly reduced interstitial edema, inflammatory cell infiltration, hemorrhage, and necrosis in a mouse model of acute pancreatitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: